About iSpecimen

Brad Callow

Director of Strategic Accounts

Brad is an integral part of the sales team, focused on strategic accounts. In this role, he is responsible for pursuing business in line with the company’s strategic plan and future vision. Brad also has experience handling finance and administration for iSpecimen, and over time has truly become the company’s culture czar.

Prior to iSpecimen, Brad was a Principal at Boston Millennia Partners, an early stage healthcare venture capital firm where he managed the deal flow team and assisted the firm in bringing multiple companies to exit. Prior to that, he worked in project management at Millennium Pharmaceuticals (acquired by Takeda) on multiple oncology drugs. Brad received his MBA from the Tuck School of Business at Dartmouth and received his BS from Tufts University.